| abstract |
A composition comprising an effective amount of at least one peptide selected from the group consisting of SEQ ID NO: 1, 2, 4, 5 and a combination thereof, in which at least one serine of the peptide is phosphorylated , for use in the treatment or improvement of a symptom of a chronic inflammatory disease or disorder, in which the chronic inflammatory disease or disorder is selected from the group consisting of muscular dystrophy (MD), fibromyalgia, myopathies, demyelinating polyradiculoneuropathy chronic inflammatory (CIDP), asthma, chronic obstructive pulmonary disease (COPD), eosinophilic inflammation of the airways and psoriasis, and the composition is administered to a patient in need of such treatment and the composition is effective in treating or improving at least a symptom of the disease or disorder. |